Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KRROKorro Bio, Inc.

Nasdaq · CIK 0001703647
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts334

Identity from submissions API

NameKorro Bio, Inc.
CIK0001703647
TickersKRRO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN472324450
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-468-1999
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Frequency Therapeutics, Inc. (2017-04-14T04:00:00.000Z → 2023-11-06T05:00:00.000Z)
Business address
60 FIRST STREET
2ND FLOOR, SUITE 250
CAMBRIDGE
MA
02141
MA
Mailing address
60 FIRST STREET
2ND FLOOR, SUITE 250
CAMBRIDGE
MA
02141
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

836 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000096 005-91158 261563176 34 19137
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005048 005-91158 261555100 34 15288
2026-11-13 4 xslF345X06/form4-11132026_101153.xml 0001030575-26-000016 15621
2026-11-12 144 xsl144X01/primary_doc.xml 0001628280-26-073489 001-39062 261548057 33 11908
2026-11-12 144 xsl144X01/primary_doc.xml 0001628280-26-073488 001-39062 261548054 33 11886
2026-11-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007553 005-91158 261543888 34 15757
2026-11-05 10-Q 10-Q 0001193125-26-448550 001-39062 261524731 34 11026411 1 1
2026-11-05 8-K 8-K 1.02,2.02,9.01 0001193125-26-448532 001-39062 261524698 34 452162 1 1
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003917 005-91158 261491774 34 11010
2026-10-26 4 xslF345X06/ownership.xml 0000902664-26-004286 14685
2026-10-22 8-K 8-K 8.01,9.01 0001193125-26-428306 001-39062 261477194 34 226164 1 1
2026-10-05 8-K 8-K 8.01,9.01 0001193125-26-414118 001-39062 261440472 34 232021 1 1
2026-09-15 4 xslF345X06/form4-09152026_040901.xml 0001030575-26-000014 11924
2026-09-14 144 xsl144X01/primary_doc.xml 0001628280-26-061898 001-39062 261378094 33 17304
2026-09-14 144 xsl144X01/primary_doc.xml 0001628280-26-061897 001-39062 261378093 33 17317
2026-09-14 4 4 0001193125-26-390556 5838
2026-09-11 144 xsl144X01/primary_doc.xml 0001628280-26-061593 001-39062 261375185 33 15944
2026-09-11 144 xsl144X01/primary_doc.xml 0001628280-26-061592 001-39062 261375178 33 15959
2026-09-11 144 xsl144X01/primary_doc.xml 0001959173-26-006900 001-39062 261374669 33 6465
2026-09-10 4 4 0001193125-26-387852 7736
2026-09-09 144 xsl144X01/primary_doc.xml 0001959173-26-006837 001-39062 261368403 33 5914
2026-09-08 144 xsl144X01/primary_doc.xml 0001959173-26-006800 001-39062 261365257 33 5282
2026-08-28 4 xslF345X06/form4-08282026_040801.xml 0001030575-26-000012 8224
2026-08-26 144 xsl144X01/primary_doc.xml 0001628280-26-059122 001-39062 261324133 33 15941
2026-08-26 144 xsl144X01/primary_doc.xml 0001628280-26-059121 001-39062 261324121 33 15960
2026-08-21 4 xslF345X06/form4-08212026_080856.xml 0001030575-26-000010 8221
2026-08-19 144 xsl144X01/primary_doc.xml 0001628280-26-058030 001-39062 261296561 33 14597
2026-08-19 144 xsl144X01/primary_doc.xml 0001628280-26-058029 001-39062 261296560 33 14616
2026-08-19 8-K 8-K 8.01 0001193125-26-356877 001-39062 261295198 34 174767 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003427 005-91158 261275816 34 15288
2026-08-13 4 xslF345X06/form4-08132026_090834.xml 0001030575-26-000008 8257
2026-08-13 4 xslF345X06/ownership.xml 0000902664-26-003434 10526
2026-08-11 144 xsl144X01/primary_doc.xml 0001628280-26-055859 001-39062 261264739 33 13261
2026-08-11 144 xsl144X01/primary_doc.xml 0001628280-26-055858 001-39062 261264738 33 13242
2026-08-06 10-Q 10-Q 0001193125-26-336707 001-39062 261245936 34 10521839 1 1
2026-08-06 8-K 8-K 1.01,2.02,3.02,9.01 0001193125-26-336685 001-39062 261245893 34 748104 1 1
2026-08-05 4 4 0001193125-26-335041 7012
2026-08-04 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001708269-26-000005 005-91158 261240164 34 37319
2026-08-04 144 xsl144X01/primary_doc.xml 0001959173-26-005626 001-39062 261239532 33 5289
2026-07-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002892 005-91158 261216926 34 10958
2026-07-17 4 4 0001193125-26-306743 5627
2026-07-17 4 4 0001193125-26-306742 5670
2026-07-17 4 4 0001193125-26-306739 5634
2026-07-17 4 4 0001193125-26-306733 5660
2026-07-07 4 xslF345X06/form4-07072026_100726.xml 0001030575-26-000006 11678
2026-07-06 144 xsl144X01/primary_doc.xml 0001628280-26-047352 001-39062 261156887 33 11883
2026-07-06 144 xsl144X01/primary_doc.xml 0001628280-26-047351 001-39062 261156885 33 11908
2026-07-02 144 xsl144X01/primary_doc.xml 0001628280-26-046980 001-39062 261152308 33 10554
2026-07-02 144 xsl144X01/primary_doc.xml 0001628280-26-046978 001-39062 261152296 33 10533
2026-06-24 4 xslF345X06/form4-06252026_120611.xml 0001030575-26-000004 18223
2026-06-24 144 xsl144X01/primary_doc.xml 0001628280-26-045302 001-39062 261117016 33 9175
2026-06-24 144 xsl144X01/primary_doc.xml 0001628280-26-045301 001-39062 261117015 33 9194
2026-06-23 144 xsl144X01/primary_doc.xml 0001628280-26-044983 001-39062 261112479 33 7836
2026-06-23 144 xsl144X01/primary_doc.xml 0001628280-26-044982 001-39062 261112478 33 7817
2026-06-22 144 xsl144X01/primary_doc.xml 0001628280-26-044738 001-39062 261108197 33 6467
2026-06-22 144 xsl144X01/primary_doc.xml 0001628280-26-044737 001-39062 261108181 33 6486
2026-06-17 4 4 0001193125-26-274171 5805
2026-06-17 4 4 0001193125-26-274156 5772
2026-06-17 4 4 0001193125-26-274143 5779
2026-06-17 4 4 0001193125-26-274136 5815
2026-06-16 144 xsl144X01/primary_doc.xml 0001959173-26-004717 001-39062 261095416 33 4567
2026-06-16 144 xsl144X01/primary_doc.xml 0001959173-26-004716 001-39062 261095350 33 4606
2026-06-16 144 xsl144X01/primary_doc.xml 0001959173-26-004715 001-39062 261095329 33 4610
2026-06-16 144 xsl144X01/primary_doc.xml 0001959173-26-004713 001-39062 261095310 33 4611
2026-06-11 4 4 0001193125-26-268018 5481
2026-06-11 4 4 0001193125-26-268012 5564
2026-06-11 4 4 0001193125-26-268006 5518
2026-06-11 4 4 0001193125-26-268001 5580
2026-06-11 4 4 0001193125-26-267996 5614
2026-06-11 4 4 0001193125-26-267993 5561
2026-06-11 8-K 8-K 5.07 0001193125-26-267741 001-39062 261083774 34 185349 1 1
2026-06-02 4 4 0001193125-26-252460 6819
2026-06-01 4 xslF345X06/form4-06012026_050601.xml 0001030575-26-000002 7696
2026-05-29 144 xsl144X01/primary_doc.xml 0001959173-26-004144 001-39062 261043258 33 4594
2026-05-28 4 4 0001193125-26-245491 6525
2026-05-19 8-K 8-K 8.01,9.01 0001193125-26-229610 001-39062 26995844 34 5918029 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003500 005-91158 26988486 34 16961
2026-05-12 424B3 424B3 0001193125-26-219703 333-294298 26969500 33 48841
2026-05-07 10-Q 10-Q 0001193125-26-210303 001-39062 26950821 34 9237525 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210291 001-39062 26950791 34 351879 1 1
2026-04-16 ARS ARS 0001193125-26-157913 001-39062 26865656 34 1981156
2026-04-16 DEFA14A DEFA14A 0001193125-26-157902 001-39062 26865650 34 1930336
2026-04-16 DEF 14A DEF 14A 0001193125-26-157895 001-39062 26865647 34 7218196 1 1
2026-04-02 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-001846 005-91158 26831548 34 10678
2026-04-02 4 xslF345X06/ownership.xml 0000902664-26-001845 7642
2026-04-02 3 xslF345X06/ownership.xml 0000902664-26-001844 6692
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001615 005-91158 26801832 34 7466
2026-03-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000894 333-294298 26779756 33 1858
2026-03-20 424B5 424B5 0001193125-26-117883 333-294298 26779031 33 192046
2026-03-18 CORRESP filename1.htm 0001193125-26-114501 8417
2026-03-18 UPLOAD filename1.pdf 0000000000-26-002740 333-294298 40236
2026-03-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-029468 005-91158 26762082 34 36066
2026-03-13 S-3 S-3 0001193125-26-106378 333-294298 26753387 33 383970 1 1
2026-03-12 4 4 0001193125-26-104721 8251
2026-03-12 4 4 0001193125-26-104720 8297
2026-03-12 4 4 0001193125-26-104719 11628
2026-03-12 4 4 0001193125-26-104717 8257
2026-03-12 4 4 0001193125-26-104718 8201
2026-03-12 4 4 0001193125-26-104716 8261
2026-03-12 4 4 0001193125-26-104715 8282
2026-03-12 4 4 0001193125-26-104713 8267
2026-03-12 4 4 0001193125-26-104714 8269
2026-03-12 4 4 0001193125-26-104712 8296
2026-03-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-26-000267 005-91158 26749573 34 82140
2026-03-12 10-K 10-K 0001193125-26-104156 001-39062 26747827 34 23105446 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-104135 001-39062 26747724 34 363280 1 1
2026-03-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001559 005-91158 26744556 34 27287
2026-03-09 8-K 8-K 1.01,2.02,3.02,7.01,9.01 0001193125-26-097575 001-39062 26733197 34 1170158 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001135 005-91158 26642102 34 17299
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000938206-26-000004 005-91158 26636972 34 6108
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015339 005-91158 26634389 34 10799
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000455 005-91158 26601935 34 11429
2026-02-03 4 4 0001193125-26-035591 8456
2026-02-03 4 4 0001193125-26-035564 5377
2026-02-03 4 4 0001193125-26-035541 5420
2026-02-03 4 4 0001193125-26-035518 5384
2026-02-03 4 4 0001193125-26-035481 5410
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000315 005-91158 26582984 34 7259
2026-01-27 S-8 S-8 0001193125-26-024394 333-292984 26565438 33 311652 1 1
2026-01-27 8-K 8-K 8.01,9.01 0001193125-26-023436 001-39062 26562241 34 17898469 1 1
2026-01-15 8-K 8-K 8.01,9.01 0001193125-26-014087 001-39062 26536290 34 1855595 1 1
2026-01-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000037 005-91158 26508071 34 14535
2025-12-18 8-K 8-K 5.02,9.01 0001193125-25-324795 001-39062 251583061 34 365596 1 1
2025-12-16 4 4 0001193125-25-320864 5020
2025-12-16 4 4 0001193125-25-320859 4987
2025-12-16 4 4 0001193125-25-320851 4994
2025-12-16 4 4 0001193125-25-320841 5030
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000938206-25-000050 005-91158 251481535 34 6821
2025-11-12 10-Q 10-Q 0001193125-25-277572 001-39062 251472766 34 9652891 1 1
2025-11-12 8-K 8-K 1.01,2.02,2.05,5.02,9.01 0001193125-25-277556 001-39062 251472717 34 443556 1 1
2025-10-08 8-K 8-K 5.02,9.01 0001193125-25-234001 001-39062 251381232 34 434214 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003690 005-91158 251220508 34 17354
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003263 005-91158 251214635 34 11483
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001532155-25-000154 005-91158 251211189 34 7649
2025-08-12 10-Q 10-Q 0000950170-25-106912 001-39062 251204004 34 9263572 1 1
2025-08-12 8-K 8-K 2.02,9.01 0000950170-25-106910 001-39062 251203999 34 404368 1 1
2025-06-18 8-K/A 8-K/A 5.07 0000950170-25-087949 001-39062 251057663 34 170412 1 1
2025-06-12 4 4 0000950170-25-085495 5340
2025-06-12 4 4 0000950170-25-085480 19903
2025-06-12 4 4 0000950170-25-085455 19865
2025-06-12 4 4 0000950170-25-085435 19903
2025-06-12 4 4 0000950170-25-085424 19969
2025-06-12 4 4 0000950170-25-085411 19901
2025-06-11 8-K 8-K 5.07 0000950170-25-084846 001-39062 251040286 34 199336 1 1
2025-05-07 10-Q 10-Q 0000950170-25-065800 001-39062 25922116 34 8736724 1 1
2025-05-07 8-K 8-K 2.02,2.05,9.01 0000950170-25-065786 001-39062 25922026 34 364780 1 1
2025-04-29 ARS ARS 0000950170-25-059536 001-39062 25882490 34 2713664
2025-04-29 DEFA14A DEFA14A 0000950170-25-059535 001-39062 25882482 34 2257472
2025-04-29 DEF 14A DEF 14A 0000950170-25-059533 001-39062 25882476 34 6407412 1 1
2025-04-01 4 4 0000950170-25-048848 5418
2025-04-01 4 4 0000950170-25-048847 5424
2025-04-01 3 3 0000950170-25-048842 15972
2025-03-27 8-K 8-K 5.02 0001193125-25-064792 001-39062 25775656 34 151777 1 1
2025-03-18 S-8 S-8 0000950170-25-040760 333-285873 25746488 33 312354 1 1
2025-03-18 10-K 10-K 0000950170-25-040759 001-39062 25746481 34 21435757 1 1
2025-03-18 8-K 8-K 2.02,9.01 0000950170-25-040755 001-39062 25746473 34 347592 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014358 005-91158 25631639 34 18489
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000938206-25-000006 005-91158 25623262 34 6597
2025-02-11 3 3 0000950170-25-017945 19923
2025-02-11 8-K 8-K 5.02 0001193125-25-024305 001-39062 25609752 34 150234 1 1
2025-02-05 4 4 0000950170-25-014574 5390
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001532155-25-000034 005-91158 25593787 34 7498
2025-02-05 4 4 0000950170-25-014551 5418
2025-02-05 4 4 0000950170-25-014517 19650
2025-02-05 4 4 0000950170-25-014515 19446
2025-02-05 4 4 0000950170-25-014478 19991
2025-01-13 8-K 8-K 8.01,9.01 0001193125-25-005020 001-39062 25524942 34 631257 1 1
2024-12-10 424B3 424B3 0001193125-24-273973 333-279402 241537145 33 143327
2024-12-10 424B3 424B3 0001193125-24-273969 333-275353 241537141 33 156488
2024-12-09 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-268954,2024-12-09 9999999995-24-003704 333-275353 241536976 33 1879
2024-12-09 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-268960,2024-12-09 9999999995-24-003707 333-279402 241536968 33 1879
2024-12-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-12-06 16:05:00 9999999995-24-003700 333-283552 241533670 33 1866
2024-12-06 424B5 424B5 0001193125-24-272557 333-283552 241533203 33 144478
2024-12-06 CORRESP filename1.htm 0001193125-24-272146 7823
2024-12-06 UPLOAD filename1.pdf 0000000000-24-013468 333-283552 40172
2024-12-02 POS AM POS AM 0001193125-24-268960 333-279402 241519545 33 218401
2024-12-02 POS AM POS AM 0001193125-24-268954 333-275353 241519514 33 233076
2024-12-02 S-3 S-3 0001193125-24-268934 333-283552 241519333 33 1242771
2024-11-21 424B3 424B3 0000950170-24-129500 333-279402 241482234 33 55029
2024-11-21 424B3 424B3 0000950170-24-129496 333-275353 241482228 33 55592
2024-11-21 8-K 8-K 8.01,9.01 0000950170-24-129488 001-39062 241482186 34 233839 1 1
2024-11-14 SC 13G/A KORRO BIO, INC. 0000902664-24-006661 005-91158 241465325 34 101754
2024-11-14 SC 13G/A cormorant-krro093024a2.htm 0001172661-24-005047 005-91158 241460747 34 88602
2024-11-14 SC 13G/A SC 13G/A 0001580642-24-006953 005-91158 241459313 34 55258
2024-11-14 SC 13G/A deeptrack-krro093024a1.htm 0001172661-24-004733 005-91158 241457693 34 103256
2024-11-12 4 4 0000950170-24-125822 22314
2024-11-12 424B3 424B3 0000950170-24-125594 333-279402 241449422 33 2218279
2024-11-12 424B3 424B3 0000950170-24-125585 333-275353 241449279 33 2218384
2024-11-12 10-Q 10-Q 0000950170-24-125362 001-39062 241448106 34 10395146 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125347 001-39062 241448019 34 342072 1 1
2024-11-12 SC 13G/A filing.txt 0000315066-24-002841 005-91158 241444872 34 8122
2024-11-12 144 xsl144X01/primary_doc.xml 0001959173-24-007649 001-39062 241443721 33 5213
2024-11-04 424B3 424B3 0000950170-24-120288 333-279402 241420764 33 87886
2024-11-04 424B3 424B3 0000950170-24-120286 333-275353 241420761 33 88466
2024-11-04 8-K 8-K 8.01,9.01 0000950170-24-120282 001-39062 241420754 34 244868 1 1
2024-10-18 4 4 0000950170-24-115723 29532
2024-10-17 144 xsl144X01/primary_doc.xml 0001959173-24-007085 001-39062 241377849 33 5098
2024-10-16 144 xsl144X01/primary_doc.xml 0001959173-24-007051 001-39062 241374067 33 5117
2024-09-16 424B3 424B3 0000950170-24-106613 333-279402 241299383 33 64123
2024-09-16 424B3 424B3 0000950170-24-106612 333-275353 241299381 33 64127
2024-09-16 8-K 8-K 1.01,9.01 0000950170-24-106611 001-39062 241299378 34 241370 1 1
2024-09-03 4 4 0000950170-24-103068 5444
2024-09-03 3 3 0000950170-24-103063 16097
2024-08-30 144 xsl144X01/primary_doc.xml 0001959173-24-006112 001-39062 241271231 33 4997
2024-08-28 4 4 0000950170-24-101535 5344
2024-08-28 3 3 0000950170-24-101529 14908
2024-08-28 424B3 424B3 0000950170-24-101402 333-279402 241255634 33 53098
2024-08-28 424B3 424B3 0000950170-24-101398 333-275353 241255557 33 53098
2024-08-28 8-K 8-K 5.02 0000950170-24-101395 001-39062 241255524 34 211182 1 1
2024-08-13 424B3 424B3 0000950170-24-096343 333-279402 241202235 33 2001153
2024-08-13 424B3 424B3 0000950170-24-096319 333-275353 241202134 33 2001616
2024-08-13 10-Q 10-Q 0000950170-24-096189 001-39062 241201450 34 8405412 1 1
2024-08-13 8-K 8-K 2.02,9.01 0000950170-24-096172 001-39062 241201396 34 325756 1 1
2024-07-12 SC 13G/A SC 13G/A 0001193125-24-178655 005-91158 241115428 34 135465
2024-06-21 424B3 424B3 0001193125-24-165729 333-275353 241060811 33 26731
2024-06-21 424B3 424B3 0001193125-24-165721 333-279402 241060786 33 26647
2024-06-21 8-K 8-K 5.02 0001193125-24-165684 001-39062 241060377 34 151464 1 1
2024-06-17 424B3 424B3 0001193125-24-162644 333-279402 241048638 33 40139
2024-06-17 424B3 424B3 0001193125-24-162626 333-275353 241048580 33 39676
2024-06-12 4 4 0000950170-24-072567 33007
2024-06-12 4 4 0000950170-24-072564 5969
2024-06-12 4 4 0000950170-24-072562 5457
2024-06-12 4 4 0000950170-24-072557 5411
2024-06-12 4 4 0000950170-24-072556 5454
2024-06-12 4 4 0000950170-24-072551 5469
2024-06-12 8-K 8-K 5.03,5.07,9.01 0001193125-24-159933 001-39062 241038410 34 182934 1 1
2024-06-04 4 4 0000950170-24-068981 5492
2024-05-22 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-05-22 16:05:00 9999999995-24-001627 333-279402 24975085 33 1889
2024-05-22 424B3 424B3 0001193125-24-145007 333-279402 24973898 33 2843648
2024-05-20 CORRESP filename1.htm 0001193125-24-142945 9210
2024-05-20 UPLOAD filename1.pdf 0000000000-24-005830 333-279402 40477
2024-05-14 3 3 0000950170-24-059950 15341
2024-05-14 S-1 S-1 0001193125-24-138296 333-279402 24945049 33 11468567 1 1
2024-05-14 424B3 424B3 0000950170-24-059597 333-275353 24944681 33 1679450
2024-05-14 8-K 8-K 8.01 0000950170-24-059498 001-39062 24944138 34 168390 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059493 001-39062 24944126 34 7355027 1 1
2024-05-14 8-K 8-K 2.02,9.01 0000950170-24-059491 001-39062 24944113 34 283145 1 1
2024-05-01 DEFA14A DEFA14A 0001193125-24-127647 001-39062 24904150 34 102259
2024-04-29 ARS ARS 0001193125-24-119977 001-39062 24886630 34 1718499
2024-04-29 DEFA14A DEFA14A 0001193125-24-119921 001-39062 24886626 34 395891
2024-04-29 DEF 14A DEF 14A 0001193125-24-119912 001-39062 24886624 34 967658
2024-04-26 SC 13G deeptrack-krro041824.htm 0001172661-24-001941 005-91158 24883382 34 103124
2024-04-24 SC 13D/A NEW ENTERPRISE ASSOCIATES 17, L.P. -- KORRO BIO, INC. 13D/A(#1) 0001072613-24-000402 005-91158 24872347 34 459150
2024-04-24 4 4 0000950170-24-047686 36481
2024-04-24 4 4 0000950170-24-047685 32895
2024-04-24 4 4 0000950170-24-047684 32992
2024-04-24 4 4 0000950170-24-047682 33027
2024-04-24 4 4 0000950170-24-047683 33027
2024-04-24 4 4 0000950170-24-047687 32991
2024-04-24 4 4 0000950170-24-047681 33032
2024-04-24 4 4 0000950170-24-047680 32985
2024-04-24 4 4 0000950170-24-047679 33001
2024-04-24 4 4 0000950170-24-047678 32907
2024-04-23 4 xslF345X05/form4-04232024_090441.xml 0001415889-24-011388 6573
2024-04-23 4 xslF345X05/form4-04232024_090431.xml 0001415889-24-011385 9338
2024-04-22 424B3 424B3 0001193125-24-105044 333-275353 24861999 33 32078
2024-04-22 8-K 8-K 8.01 0001193125-24-105037 001-39062 24861957 34 160376 1 1
2024-04-19 PRE 14A PRE 14A 0001193125-24-102873 001-39062 24857796 34 967846
2024-04-18 424B3 424B3 0001193125-24-100078 333-275353 24852976 33 41157
2024-04-18 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-24-100069 001-39062 24852960 34 524749 1 1
2024-03-28 424B3 424B3 0001193125-24-080472 333-275353 24798257 33 2427831
2024-03-27 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-077704,2024-03-27 9999999995-24-000737 333-275353 24793233 33 1902
2024-03-26 POS AM POS AM 0001193125-24-077704 333-275353 24784601 33 9469630 1 1
2024-03-26 S-8 S-8 0001193125-24-077693 333-278245 24784523 33 64900
2024-03-26 8-K 8-K 2.02,9.01 0001193125-24-077613 001-39062 24783693 34 211893 1 1
2024-03-26 10-K 10-K 0000950170-24-036396 001-39062 24783456 34 12934532 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023932 005-91158 24639955 34 137994
2024-02-14 SC 13G/A AMENDMENT NO. 1 0000929638-24-000646 005-91158 24636528 34 111235
2024-02-14 SC 13G SC 13G 0001580642-24-000981 005-91158 24634723 34 55933
2024-02-09 SC 13G filing.txt 0000315066-24-001202 005-91158 24611786 34 8267
2024-01-09 424B3 424B3 0001193125-24-004913 333-275353 24521905 33 12757581
2024-01-09 8-K 8-K 8.01,9.01 0001193125-24-004911 001-39062 24521901 34 12895366 1 1
2023-12-22 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-12-22 16:05:00 9999999995-23-003727 333-275353 231511230 33 1890
2023-12-22 424B3 424B3 0001193125-23-302159 333-275353 231510288 33 18814017
2023-12-21 CORRESP filename1.htm 0001193125-23-301172 10249
2023-12-20 CORRESP filename1.htm 0001193125-23-299991 17505
2023-12-20 S-1/A S-1/A 0001193125-23-299978 333-275353 231501826 33 19156238
2023-12-06 UPLOAD filename1.pdf 0000000000-23-013306 43446
2023-12-01 CORRESP filename1.htm 0001193125-23-287463 41991
2023-12-01 S-1/A S-1/A 0001193125-23-287451 333-275353 231459559 33 40426261 1 1
2023-11-29 4 4 0000950170-23-066806 5300
2023-11-29 3 3 0000950170-23-066803 13660
2023-11-29 8-K FORM 8-K 5.02 0001193125-23-285164 001-39062 231452099 34 150204 1 1
2023-11-27 4 4 0000950170-23-066217 20653
2023-11-22 144 xsl144X01/primary_doc.xml 0001959173-23-004954 001-39062 231433742 33 5081
2023-11-22 4 4 0000950170-23-065866 21644
2023-11-20 144 xsl144X01/primary_doc.xml 0001959173-23-004882 001-39062 231422522 33 5737
2023-11-17 UPLOAD filename1.pdf 0000000000-23-012663 44936
2023-11-17 SC 13G SC 13G 0001193125-23-279807 005-91158 231419080 34 54314
2023-11-17 SC 13D NEW ENTERPRISE ASSOCIATES 17, L.P. -- KORRO BIO, INC. 13D 0001072613-23-000581 005-91158 231417362 34 453371
2023-11-16 SC 13G schedule13g.htm 0000929638-23-003149 005-91158 231414556 34 127689
2023-11-14 8-K 8-K 5.02,9.01 0001193125-23-277147 001-39062 231407069 34 341107 1 1
2023-11-13 SC 13G SC 13G 0001104659-23-117276 005-91158 231399435 34 143316
2023-11-13 SC 13G SC 13G 0001193125-23-276083 005-91158 231399339 34 151934
2023-11-13 SC 13D SC 13D 0001104659-23-117226 005-91158 231398928 34 137494
2023-11-13 144 xsl144X01/primary_doc.xml 0001959173-23-004658 001-39062 231395863 33 9646
2023-11-13 144 xsl144X01/primary_doc.xml 0001959173-23-004651 001-39062 231395565 33 4441
2023-11-13 144 xsl144X01/primary_doc.xml 0001959173-23-004643 001-39062 231395261 33 9629
2023-11-13 144 xsl144X01/primary_doc.xml 0001959173-23-004641 001-39062 231395180 33 9618
2023-11-09 SC 13G KORRO BIO, INC. 0000902664-23-005426 005-91158 231392997 34 114674
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054649 4342
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054648 4384
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054647 4254
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054646 4389
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054644 4348
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054643 4386
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054642 4338
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054641 4252
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054640 7724
2023-11-07 4 4 0000950170-23-060611 9461
2023-11-07 4 4 0000950170-23-060610 9500
2023-11-07 4 4 0000950170-23-060608 11181
2023-11-07 4 FORM 4 SUBMISSION 0001209191-23-054637 9415
2023-11-07 4 4 0000950170-23-060607 15217
2023-11-07 4 4 0000950170-23-060606 17302
2023-11-07 4 4 0000950170-23-060602 15217
2023-11-07 4 4 0000950170-23-060599 5296
2023-11-07 4 4 0000950170-23-060597 11816
2023-11-07 3 3 0000950170-23-060594 14609
2023-11-07 3 3 0000950170-23-060593 17045
2023-11-07 3 FORM 3 SUBMISSION 0001209191-23-054636 2965
2023-11-07 3 3 0000950170-23-060591 18780
2023-11-07 3 3 0000950170-23-060590 18803
2023-11-07 3 3 0000950170-23-060587 19069
2023-11-07 3 3 0000950170-23-060581 17038
2023-11-07 3 3 0000950170-23-060580 18436
2023-11-07 3 3 0000950170-23-060579 16182
2023-11-07 3 3 0000950170-23-060577 14440
2023-11-06 S-8 S-8 0001193125-23-271472 333-275354 231380849 33 102863
2023-11-06 S-3 S-3 0001193125-23-271471 333-275353 231380839 33 403276
2023-11-06 8-K 8-K 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.07,7.01,8.01 0001193125-23-270898 001-39062 231378423 34 5381821 1 1
2023-11-02 10-Q 10-Q 0000950170-23-058171 001-39062 231372194 34 7672618 1 1
2023-10-25 425 425 0001193125-23-262972 001-39062 231345679 34 23738
2023-10-12 SC 13G SC 13G 0001193125-23-254984 005-91158 231322776 34 37745
2023-09-29 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-09-29 16:00:00 9999999995-23-002873 333-273490 231297493 33 1718
2023-09-29 424B3 424B3 0001193125-23-247405 333-273490 231295752 33 11205599
2023-09-28 CORRESP filename1.htm 0001193125-23-244642 7148
2023-09-28 S-4/A S-4/A 0001193125-23-244637 333-273490 231286065 33 26765154 1 1
2023-09-27 425 425 0001193125-23-243676 001-39062 231284822 34 25095
2023-09-27 8-K 8-K 1.02,8.01 0001193125-23-243671 001-39062 231284800 34 158369 1 1
2023-09-21 S-4/A S-4/A 0001193125-23-238780 333-273490 231267556 33 26990815 1 1
2023-09-20 CORRESP filename1.htm 0001193125-23-238785 130698
2023-09-15 UPLOAD filename1.pdf 0000000000-23-010215 52296
2023-09-01 S-4/A S-4/A 0001193125-23-226463 333-273490 231230065 33 28532710 1 1
2023-08-31 CORRESP filename1.htm 0001193125-23-226467 96160
2023-08-24 UPLOAD filename1.pdf 0000000000-23-009296 73938
2023-08-22 4 PRIMARY DOCUMENT 0001127602-23-023082 7748
2023-08-22 4 PRIMARY DOCUMENT 0001127602-23-023081 7077
2023-08-21 144 xsl144X01/primary_doc.xml 0001959173-23-003418 001-39062 231189017 33 24137
2023-08-21 144 xsl144X01/primary_doc.xml 0001959173-23-003417 001-39062 231189005 33 24384
2023-08-21 144 xsl144X01/primary_doc.xml 0001959173-23-003415 001-39062 231188956 33 24367
2023-08-18 144 xsl144X01/primary_doc.xml 0001959173-23-003397 001-39062 231186867 33 23737
2023-08-18 144 xsl144X01/primary_doc.xml 0001959173-23-003384 001-39062 231186239 33 23764
2023-08-18 144 xsl144X01/primary_doc.xml 0001959173-23-003375 001-39062 231185616 33 23474
2023-08-18 4 PRIMARY DOCUMENT 0001127602-23-022902 7702
2023-08-18 4 PRIMARY DOCUMENT 0001127602-23-022901 7031
2023-08-17 144 xsl144X01/primary_doc.xml 0001959173-23-003351 001-39062 231181737 33 23126
2023-08-17 144 xsl144X01/primary_doc.xml 0001959173-23-003343 001-39062 231181542 33 22968
2023-08-17 144 xsl144X01/primary_doc.xml 0001959173-23-003341 001-39062 231181493 33 22881
2023-08-16 144 xsl144X01/primary_doc.xml 0001959173-23-003303 001-39062 231178106 33 22260
2023-08-16 144 xsl144X01/primary_doc.xml 0001959173-23-003300 001-39062 231178073 33 22487
2023-08-16 144 xsl144X01/primary_doc.xml 0001959173-23-003299 001-39062 231178040 33 22507
2023-08-16 4 PRIMARY DOCUMENT 0001127602-23-022638 7702
2023-08-16 4 PRIMARY DOCUMENT 0001127602-23-022636 7031
2023-08-15 8-K 8-K 1.02 0001193125-23-213436 001-39062 231174878 34 148116 1 1
2023-08-15 144 xsl144X01/primary_doc.xml 0001959173-23-003264 001-39062 231174752 33 21850
2023-08-15 144 xsl144X01/primary_doc.xml 0001959173-23-003263 001-39062 231174737 33 21657
2023-08-15 144 xsl144X01/primary_doc.xml 0001959173-23-003257 001-39062 231174619 33 21869
2023-08-14 4 PRIMARY DOCUMENT 0001127602-23-022479 7031
2023-08-14 4 PRIMARY DOCUMENT 0001127602-23-022478 7702
2023-08-14 144 xsl144X01/primary_doc.xml 0001959173-23-003216 001-39062 231169319 33 21222
2023-08-14 144 xsl144X01/primary_doc.xml 0001959173-23-003214 001-39062 231169298 33 21248
2023-08-14 144 xsl144X01/primary_doc.xml 0001959173-23-003212 001-39062 231169224 33 21028
2023-08-11 144 xsl144X01/primary_doc.xml 0001959173-23-003161 001-39062 231163804 33 20432
2023-08-11 144 xsl144X01/primary_doc.xml 0001959173-23-003158 001-39062 231163679 33 20593
2023-08-11 144 xsl144X01/primary_doc.xml 0001959173-23-003155 001-39062 231163590 33 20611
2023-08-10 10-Q 10-Q 0000950170-23-041300 001-39062 231159317 34 8704589 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041285 001-39062 231159235 34 358617 1 1
2023-08-10 4 PRIMARY DOCUMENT 0001127602-23-022281 7031
2023-08-10 4 PRIMARY DOCUMENT 0001127602-23-022279 7702
2023-08-10 144 xsl144X01/primary_doc.xml 0001959173-23-003110 001-39062 231159055 33 19803
2023-08-10 144 xsl144X01/primary_doc.xml 0001959173-23-003109 001-39062 231159018 33 19982
2023-08-10 144 xsl144X01/primary_doc.xml 0001959173-23-003106 001-39062 231158999 33 19964
2023-08-09 144 xsl144X01/primary_doc.xml 0001959173-23-003063 001-39062 231154871 33 19178
2023-08-09 144 xsl144X01/primary_doc.xml 0001959173-23-003062 001-39062 231154846 33 19349
2023-08-09 144 xsl144X01/primary_doc.xml 0001959173-23-003060 001-39062 231154836 33 19331
2023-08-09 4 PRIMARY DOCUMENT 0001127602-23-022219 7031
2023-08-09 4 PRIMARY DOCUMENT 0001127602-23-022218 7702
2023-08-08 144 xsl144X01/primary_doc.xml 0001959173-23-003031 001-39062 231150844 33 18724
2023-08-08 144 xsl144X01/primary_doc.xml 0001959173-23-003030 001-39062 231150843 33 18538
2023-08-08 144 xsl144X01/primary_doc.xml 0001959173-23-003028 001-39062 231150820 33 18714
2023-08-07 144 xsl144X01/primary_doc.xml 0001959173-23-002988 001-39062 231147843 33 17921
2023-08-07 144 xsl144X01/primary_doc.xml 0001959173-23-002980 001-39062 231147365 33 18094
2023-08-07 144 xsl144X01/primary_doc.xml 0001959173-23-002978 001-39062 231147345 33 18077
2023-08-04 144 xsl144X01/primary_doc.xml 0001959173-23-002949 001-39062 231144532 33 17440
2023-08-04 4 PRIMARY DOCUMENT 0001127602-23-022010 7031
2023-08-04 4 PRIMARY DOCUMENT 0001127602-23-022007 7702
2023-08-04 144 xsl144X01/primary_doc.xml 0001959173-23-002942 001-39062 231143801 33 17459
2023-08-04 144 xsl144X01/primary_doc.xml 0001959173-23-002936 001-39062 231143716 33 17206
2023-08-03 144 xsl144X01/primary_doc.xml 0001959173-23-002883 001-39062 231139659 33 16822

Latest XBRL company facts

One latest value per concept from companyfacts (334 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 13.73M 2026-11-03 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
dei EntityPublicFloat Entity Public Float USD 88.97M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-104156
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 384,425 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001193125-26-157895
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.80M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001193125-26-157895
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 4 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001193125-26-157895
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 1.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 2.76M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 25,000 2020-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025273
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 514,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 16.00M 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 11.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -305,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 540.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 236.16M 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.81M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AffiliateCosts Affiliate Costs USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.80M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277572
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 15.00M 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap Assets Assets USD 148.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AssetsCurrent Assets, Current USD 108.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 5,000 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 85.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 395,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 84.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016072
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 40.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 42.62M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 17.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 7.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 14.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 13.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap CommonStockValue Common Stock, Value, Issued USD 14,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -56.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 18.30M 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-096189
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 14.07M 2020-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003655
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 2.90M 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 151.72M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 636,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 637,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 5.38M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.093 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0000950170-23-021755
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Securities 0 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 4.00M 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -150,000 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-12 0001564590-20-039488
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 213,000 2022-12-31 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Term 14 2022-12-31 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap DebtSecuritiesHeldToMaturityAllowanceForCreditLoss Debt Securities, Held-to-maturity, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 518,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 2.46M 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.20M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.46M 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 4.83M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 478,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 204.55M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 33.65M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.20M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 124.62M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 11.88M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 11.16M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.38M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.39M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 202.34M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxLiabilitiesDeferredExpense Deferred Tax Liabilities, Deferred Expense USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.20M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 550,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.05 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage pure 1 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.9 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap Depreciation Depreciation USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.28 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016072
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.219 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.13 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 251,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.028 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.027 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal Effective Income Tax Rate Reconciliation, Tax Contingency, State and Local, Percent pure 0.037 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 300,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.87M 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 23.89M 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023231
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 9.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 4.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -5,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactions Future Minimum Sublease Rentals, Sale Leaseback Transactions USD 765,000 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsRemainderOfFiscalYear Future Minimum Sublease Rentals, Sale Leaseback Transactions, Remainder of Fiscal Year USD 593,000 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023231
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next Twelve Months USD 574,000 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Two Years USD 191,000 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -269,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 20.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 805,000 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue Debt Securities, Held-to-maturity, Unrealized Loss Position, Fair Value USD 27.23M 2022-12-31 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value USD 17.30M 2022-12-31 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value USD 9.93M 2022-12-31 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -117.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -55.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 1.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -26.48M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -84.67M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003655
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 109,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 463,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 25.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 384,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -24.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 485,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -73,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -1.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -969,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -2.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.47M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 25.47M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -186,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 0 2023-11-03 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap InterestExpense Interest Expense USD 284,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap InterestExpenseDebt Interest Expense, Debt USD 284,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 914,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.32M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 54,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap LeaseCost Lease, Cost USD 6.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 61.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 36.71M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 7.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 28.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 8.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 8.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 7.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 20.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap Liabilities Liabilities USD 59.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 148.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LiabilitiesCurrent Liabilities, Current USD 14.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 180,000 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap LongTermLoansFromBank Loans Payable to Bank, Noncurrent USD 0 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 600,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003655
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2024-03-31 2024 Q1 10-Q 2024-05-14 0000950170-24-059493
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap MarketableSecurities Marketable Securities USD 124.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 64.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 19.83M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 85.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -21.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -46.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -56.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -84.69M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003655
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingExpenses Operating Expenses USD 59.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -59.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 4.80M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 41.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 38.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingLeasePayments Operating Lease, Payments USD 484,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 25.74M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 40.22M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 4.27M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 4.67M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 4.53M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.40M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.28M 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003655
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 22.34M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 151,000 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054017
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 269,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.112 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 118,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherAssetsCurrent Other Assets, Current USD 255,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD -41,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -116,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 208,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap OtherComprehensiveIncomeOtherNetOfTax Other Comprehensive Income, Other, Net of Tax USD 0 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277572
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -558,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 296,000 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023231
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 260,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016072
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 3.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 396,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 2.46M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054017
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 26.34M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 87.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 85,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio Rate 0.05 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 1.90M 2023-11-03 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PrepaidInsurance Prepaid Insurance USD 1.61M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 5.00M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 80.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 266,000 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-12 0001564590-20-039488
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 15.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003655
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments Proceeds from Maturities, Prepayments and Calls of Other Investments USD 65.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 3.77M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 5.00M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 33.54M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 43.42M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 33,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -56.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 18.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 7.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 3,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap RecapitalizationCosts Recapitalization Costs USD 12.25M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 3.77M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 14.17M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap RepaymentsOfLongTermDebtAndCapitalSecurities Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security USD 833,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 38.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestrictedCash Restricted Cash USD 2.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 42.62M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.00M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestrictedCashEquivalentsNoncurrent Restricted Cash Equivalents, Noncurrent USD 2.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.55 2023-02-13 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap RestructuringCharges Restructuring Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestructuringCosts Restructuring Costs USD 26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestructuringReserve Restructuring Reserve USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RestructuringReserveAcceleratedDepreciation Restructuring and Related Cost, Accelerated Depreciation USD 360,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -439.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap Revenues Revenues USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 5.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 31.34M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003655
us-gaap RoyaltyExpense Royalty Expense USD 16.00M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap SeveranceCosts1 Severance Costs USD 3.84M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 9.25M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.783 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 24.66 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 129,843 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 452,862 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.71 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 16,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 22.5 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 6.67M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 8,898 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001564590-21-043699
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 11.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 29.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 12.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap ShortTermInvestments Short-term Investments USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 570,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 88.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.148 2019-09-19 2019-09-20 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1,487 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 33,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 6,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040759
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 61,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 5,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036396
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 17,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap StockOptionExercisePriceDecrease Stock Option, Exercise Price, Decrease USD/shares 2.14 2022-08-17 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap SubleaseIncome Sublease Income USD 1.77M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058171
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 28.04M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 0 2017-12-22 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 147.90M 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 1.05M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-016117
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 147.71M 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 114.21M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-012977
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 144.19M 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 144.19M 2019-09-30 2019 Q3 10-Q 2019-11-18 0001564590-19-043670
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap TreasuryStockValue Treasury Stock, Value USD 12.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 553,000 2024-07-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277572
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007140
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 34.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104156
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 15.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 34.89M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016072
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 15.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448550

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →